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Abstract. Peucedanum officinale, (fam. Apiaceae), belongs to a large group of medicinal plants, spread 
around the world, used for wide range therapeutic purposes. Antiinflammatory action has been tested on kaolin 
rat paw oedema model (measured by plethysmography), efficiency of Peucedanum officinale, has been 
compared to those of phenylbutazone. Inflammatory oedema represent the difference between the injected paw 
volume at 2, 4, respectively 24 hours and initial volume; the inhibition of oedema represents the difference in 
paw volume, between treated animals (Peucedanum officinale and phenylbutazone) and untreated ones. Acute 
toxicity test has revealed no pathological changes in animals in study. Antiinflammatory effect reflected by 
inhibition of oedema has the highest value on 4h determination, but the difference to negative control group was 
statistically significant in all the determinations. However, the antiinflammatory efficiency has been lower as 
compared to phenylbutazone. Peucedanum officinale has proved a significant antiinflammatory activity; 
therefore, it might be useful for patients unsuitable for classical antiinflammatory therapy. 
 
INTRODUCTION 
 
Inflammation is one of the most common tissue responses to various injuries; therefore 
inflammatory diseases are common in both human and veterinary medicine. In the last years, 
highly effective new antiinflammatory drugs have been introduced, but unfortunately most of 
them are responsible for various side effects, especially in high sensitive patients like 
pregnant women, now born children, elderly people, etc. World wide, there is an increasing 
concern in finding new antiinflammatory remedies, not only effective, but also harmless; in 
this respect plant natural extracts are in focus.  
Peucedanum officinale, (fam. Apiaceae), belongs to a large group of medicinal plants, 
spread around the world, used for wide range therapeutic purposes. In Romania, Peucedanum 
is represented not only by P. officinale, but a large number of species like P. rochelianum, P. 
alsaticum, P. arenarium, P. cervaria, P. longifolium, P. palustre, P. oreoselinum, P. cervaria, 
P. graveolens. Those plants contain various therapeutic compounds, but coumarins have the 
main antiflogistic properties. Coumarins have proved the antiinflammatory effect in other 
species of Peucedanum (Hiermann and Schantl 1998), and, also, in other medicinal plants like 
Melilotus officinalis (Plesca-Manea et. al. 2002).  
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MATERIAL AND METHOD. 
 
Acute toxicity test for Peucedanum officinale has been assessed on 5 white female 
Wistar rats, in average body weight 112.45±10.25 g, two days consequently, 250 mg / animal 
every day. In the end the blood samples were harvested by retroorbitary sinus under deep 
narcosis than the animals were euthanasiated by prolonged narcosis. Later necropsy was done 
in order to reveal any gross lesions. Complete haematological examination was made by using 
Abacus Junior Vet automatic counter.  
Antiinflammatory action has been tested on rat paw oedema model (measured by 
plethysmography). 24 white male Wistar rats, in average body weight 128.45±13.30 g, have 
been used; they were breed according to standard conditions and fed on standard diet. The 
antiinflammatory efficiency of Peucedanum officinale, has been compared to those of 
phenylbutazone.  
The access to food was restricted 24 hours before the start of the experimental 
procedure. In the beginning of experiment, the substances were administrated dissolved in 1 
ml distillated water, by esophageal sondage, using a urinary sterile catheter for cats, as 
follows:  
Negative control group – distillated water  
Positive control group – phenylbutazone 7.5 mg /animal (50 mg/kg) 
Experimental group - Peucedanum officinale 25 mg / animal 
One hour latter, suspension of kaolin 10% was intraplantary injected. The 
measurements, made by UGO BASILE 7140 digital plethysmometer, were done before kaolin 
injection (for assessing the initial volume of paw), and in 2, 4 and 24 hours after the injection. 
Inflammatory oedema (calculated for each animal in study) represent the difference between 
the injected paw volume at 2, 4, respectively 24 hours and initial volume (iV). The inhibition 
of oedema (IO) represents the difference in paw volume, between treated animals (positive 
control group and experimental group) and untreated ones (negative control). The percentage 
of IO has been calculated according to formula: 
IO % = (1 – M treated group/ M untreated group) x 100  
M treated group = the average of inflammatory oedema in treated animals 
(phenylbutazone or Peucedanum officinale) 
M untreated group = the average of inflammatory oedema in untreated animals 
(negative control).  
Statistical analyses. The levels of paw oedema were expressed as the mean and standard 
deviation. T Student multiple range test from Excel Windows Software was used to assess the 
differences among groups. Differences at p<0.05 and p<0.001 were considered significant and 
respectively distinct significant. 
 
RESULTS AND DISCUSSIONS 
 
Acute toxicity test has revealed no pathological changes in animals in study; they have 
not shown any clinical symptom, and no lesions at necropsy have been found. Hematological 
profile has been within normal limits. This toxicity test has had a crucial importance, because 
coumarinic compounds have been responsible for various intoxications, consisting especially 
in hemorrhagic syndromes. Anticlotting effect is achieved trough two main pathways: 
preventing the platelets agglutination and anti K vitamin activity.  
Kaolin induced paw oedema test proved the efficiency of Peucedanum officinale extract, 
the antiinflammatory effect reflected by inhibition of oedema has the highest value on 4h 
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determination (like the most antiinflammatory drugs), but have been found in all 
measurements (2, 4 and 24 hours). The difference to negative control group was statistically 
significant in all the determinations. As compared to phenylbutazone, the effect was lower in 
the first day (in 2 and 4 hour administration), but remarkably, in the second day (24 hours) the 
values were very close, so, Peucedanum officinale seems to provide a better long term effect 
(Table 1.).  
 
Table 1. 
Antiinflammatory activity of Peucedanum officinale on rat paw oedema model. 
 V2h-iV V4h-iV V24h -iV IO 2h IO 4h IO 24h 
Control 0.88±0.26 1.06±0.35 1.39±0.40    
Peucedanum 0.65±0.11* 0.74±0.18* 1.05±0.14* 26.64% 30.84% 24.65% 
Phenylbutazone  0.52±0.17* 0.55±0.20** 1.02±0.24 41.26% 47.83% 27.16% 
IO = inhibition of oedema 
*and** = statistically significant as compared to control at p<0.05 and p<0.001 
 
Coumarins (and especially pyranocoumarins) are highly effective in treatment of 
inflammatory oedemas due to various mechanisms. In isolated smooth muscle of rat and in 
the isolated guinea pig ileum, coumarins showed noncompetitive antagonistic effects on 
acetylcholine and histamine (Aida et al., 1998). Coumarinic compounds have also the ability 
to inhibit the lipid peroxidation and to scavenge the reactive oxygen species (Paya et al. 
1992). Hiermann and Schantl 1998 have proved that coumarins act as dual inhibitors of 
cyclooxygenase and 5-lipoxygenase activities. In fact, many Peucedanum species contain not 
only coumarins, but a high number of antioxidant compounds (Hisamoto et al. 2003). 
This mechanisms make coumarins effective not only in antiinflammatory therapy, but in 
other pathology sharing common pathways to inflammation, like in preventing 
thrombogenesis (Chen .et al., 1996, Hsiao et al., 1998), antipyretic effect (Hiermann and 
Schantl 1998) or antiallergic and spasmolytic effect (Aida et al., 1998). A similar activity was 
found also in related substances like flavonoids (commonly occurring in various species of 
Peucedanum) (Hisamoto et al. 2003).  
Kaolin induced paw oedema, has been commonly used as experimental model for acute 
inflammation. The early phase (1-2h) is mainly mediated by histamine and serotonin, while 
later phase is sustained by prostaglandin release and mediated by bradykinin leukotrienes, 
polymorphonuclear cells and prostaglandins produced by tissue macrophages (Brito and 
Antonio, 1998). The efficiency of the present Peucedanum extract, found in all two phases of 
kaolin induced paw oedema, suggest the involvement of both mechanisms (agonistic effect to 
histamine and down regulation of cyclooxygenase activity), moreover the level of inhibition 
relatively constant in the second day suggest a subacute antiinflammatory effect. This finding 
recommends Peucedanum for further tests on subacute and chronic animal inflammatory 
models. However, is important to remark that the antiinflammatory efficiency has been lower 
as compared to classic nesteroidian antiinflammatory drug (phenylbutazone). To reduce this 
disadvantage in further experiences a higher doses should be used, in order to establish if the 
efficiency of Peucedanum compounds is dose related or not; higher doses might be consider 
safe because no over dosage risk has been found. Even in lower efficiency than classical 
antiinflammatory drugs, this plant extract might be useful for many patients unsuitable for 
classical antiinflammatory therapy.  
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CONCLUSIONS 
 
Peucedanum officinale has proved a significant antiinflammatory activity on kaolin 
induced rat paw oedema model, however the efficiency has been found lower than classic 
antiinflammatory therapy (phenylbutazone). The extract in study has shown no toxicity, even 
in doses 10 times higher than therapeutic dosage. 
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